rs587118

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004629.2(FANCG):​c.1636+7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 1,613,706 control chromosomes in the GnomAD database, including 171,513 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 12186 hom., cov: 32)
Exomes 𝑓: 0.45 ( 159327 hom. )

Consequence

FANCG
NM_004629.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00009051
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.479

Publications

24 publications found
Variant links:
Genes affected
FANCG (HGNC:3588): (FA complementation group G) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008]
FANCG Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group G
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 9-35074920-T-C is Benign according to our data. Variant chr9-35074920-T-C is described in ClinVar as Benign. ClinVar VariationId is 259477.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.492 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004629.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCG
NM_004629.2
MANE Select
c.1636+7A>G
splice_region intron
N/ANP_004620.1O15287

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCG
ENST00000378643.8
TSL:1 MANE Select
c.1636+7A>G
splice_region intron
N/AENSP00000367910.4O15287
FANCG
ENST00000425676.5
TSL:1
n.*1112+7A>G
splice_region intron
N/AENSP00000412793.1F8WC08
FANCG
ENST00000448890.2
TSL:3
c.1636+7A>G
splice_region intron
N/AENSP00000409607.2O15287

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53601
AN:
152010
Hom.:
12180
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0912
Gnomad AMI
AF:
0.421
Gnomad AMR
AF:
0.457
Gnomad ASJ
AF:
0.371
Gnomad EAS
AF:
0.00520
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.497
Gnomad OTH
AF:
0.392
GnomAD2 exomes
AF:
0.402
AC:
100982
AN:
251416
AF XY:
0.403
show subpopulations
Gnomad AFR exome
AF:
0.0803
Gnomad AMR exome
AF:
0.501
Gnomad ASJ exome
AF:
0.378
Gnomad EAS exome
AF:
0.00321
Gnomad FIN exome
AF:
0.502
Gnomad NFE exome
AF:
0.500
Gnomad OTH exome
AF:
0.455
GnomAD4 exome
AF:
0.452
AC:
660467
AN:
1461578
Hom.:
159327
Cov.:
45
AF XY:
0.448
AC XY:
325966
AN XY:
727106
show subpopulations
African (AFR)
AF:
0.0767
AC:
2569
AN:
33478
American (AMR)
AF:
0.495
AC:
22127
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
9703
AN:
26134
East Asian (EAS)
AF:
0.00406
AC:
161
AN:
39700
South Asian (SAS)
AF:
0.263
AC:
22664
AN:
86244
European-Finnish (FIN)
AF:
0.500
AC:
26708
AN:
53396
Middle Eastern (MID)
AF:
0.368
AC:
2119
AN:
5762
European-Non Finnish (NFE)
AF:
0.495
AC:
549927
AN:
1111750
Other (OTH)
AF:
0.406
AC:
24489
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
20478
40956
61435
81913
102391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15500
31000
46500
62000
77500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.352
AC:
53603
AN:
152128
Hom.:
12186
Cov.:
32
AF XY:
0.350
AC XY:
26015
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0909
AC:
3775
AN:
41534
American (AMR)
AF:
0.458
AC:
6997
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
1287
AN:
3470
East Asian (EAS)
AF:
0.00540
AC:
28
AN:
5184
South Asian (SAS)
AF:
0.235
AC:
1133
AN:
4824
European-Finnish (FIN)
AF:
0.505
AC:
5325
AN:
10552
Middle Eastern (MID)
AF:
0.357
AC:
105
AN:
294
European-Non Finnish (NFE)
AF:
0.497
AC:
33755
AN:
67970
Other (OTH)
AF:
0.387
AC:
815
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1544
3088
4633
6177
7721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.455
Hom.:
24407
Bravo
AF:
0.338
Asia WGS
AF:
0.137
AC:
481
AN:
3478
EpiCase
AF:
0.487
EpiControl
AF:
0.494

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Fanconi anemia complementation group G (5)
-
-
2
Fanconi anemia (2)
-
-
2
not provided (2)
-
-
1
Amyotrophic Lateral Sclerosis, Dominant (1)
-
-
1
Inclusion Body Myopathy, Dominant (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
9.8
DANN
Benign
0.81
PhyloP100
0.48
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000091
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587118; hg19: chr9-35074917; COSMIC: COSV62719986; COSMIC: COSV62719986; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.